Preview

Russian Journal of Cardiology

Advanced search

REAL-WORLD AMBULATORY AND CLINICAL MANAGEMENT OF HIGH-RISK PATIENTS WITH ARTERIAL HYPERTENSION

Abstract

To analyze ambulatory and clinical tactics in target blood pressure (BP) achievement, 60 ambulatory medical cards and 60 hospital medical histories of patients with arterial hypertension (AH) were analyzed. Target BP levels were registered in 60% of ambulatory patients. Despite the fact that 93,3% of the patients needed more aggressive antihypertensive treatment, only in 37%, such an attempt (increasing the dose and/or administering combined therapy) had been done. The mean number of medications had decreased during the control year. Thiazide diuretics (TD) and calcium antagonists (CA) were rarely administered. By the end of the control year, target BP levels were achieved in 15% only. Therapy change frequency in those achieving and not achieving target BP levels varied from 0 to 14 (on average, 3,8), mostly due to “incorrect” prescriptions. Target BP level achievers received ACE inhibitors and TD more often. The main reason for hospitalization was uncontrolled AH (67,5%) due to irregular regimen of pharmaceutical therapy (64,9%). During the hospitalization, target BP levels were achieved in 97,5%, at Day 9 on average. After admission, most patients received combined three-component therapy, including TD and CA. The АВС/VEN-analysis demonstrated low prevalence of effective medication administration and a three-fold increase in the second-choice medication use. The results obtained confirm the potential for target BP level achievement in high and very high-risk AH patients, and demonstrated real-world mistakes in ambulatory management of AH.

About the Authors

S. V. Mal’chikova
Кировская государственная медицинская академия, Киров
Russian Federation


E. I. Tarlovskaya
Кировская государственная медицинская академия, Киров
Russian Federation


References

1. Chobanian AV, Bakris GL, Blorck HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure// JAMA 2003; 289: 2560- 2572.

2. National Guidelines for the Management of Arterial Hypertension European Society of Hypertension – 2007 Guidelines for the Management of Arterial Hypertension of the European Society of Hypertension.

3. Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Российские рекомендации (третий пересмотр). Комитет экспертов Всероссийского научного общества кардиологов и Российского медицинского общества по артериальной гипертонии. Москва, 2008.

4. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial// Lancet 1998; 351: 1755- 1762.

5. Беленков Ю.Н., Чазова И.Е. Первое российское национальное многоцентровое исследование – РОСА (Российское исследование Оптимального Снижения Артериального давления)// Артериальная гипертензия. 2003; 5: 151-154.

6. Остроумова О.Д., Мамаев В.И. Фармакоэкономические аспекты лечения артериальной гипертонии// Артериальная гипертензия 2002; 6: 193-199.


Review

For citations:


Mal’chikova S.V., Tarlovskaya E.I. REAL-WORLD AMBULATORY AND CLINICAL MANAGEMENT OF HIGH-RISK PATIENTS WITH ARTERIAL HYPERTENSION. Russian Journal of Cardiology. 2009;(3):33-39. (In Russ.)

Views: 551


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)